Trial Profile
Clinical Trials Insight: 700029703
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2010
Price :
$35
*
At a glance
- Drugs SP 233 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 07 Jan 2008 New trial record.